Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke?

Michael J. Poellmann, Jiyoon Bu, Seungpyo Hong

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Ischemic stroke is a leading cause of death and disability worldwide and is in urgent need of new treatment options. The only approved treatment for stroke restores blood flow to the brain, but much of the tissue damage occurs during the subsequent reperfusion. Antioxidant therapies that directly address ischemia-reperfusion injury have shown promise in preclinical results. In this review, we discuss that reformulating antioxidant therapies as nanomedicine can potentially overcome the barriers that have kept these therapies from succeeding in the clinic. We begin by reviewing the pathophysiology of ischemic stroke with a focus on the effects of reperfusion injury. Next, we review nanotherapeutic systems designed to treat the disease with a focus on those addressing reperfusion injury. Mechanisms of passive and active transport required to traverse a blood-brain barrier are discussed. Finally, we conclude by outlining design parameters for potentially successful nanomedicines as front-line therapeutics for ischemic stroke.

Original languageEnglish
Pages (from-to)2327-2340
Number of pages14
JournalNanomedicine
Volume13
Issue number18
DOIs
Publication statusPublished - 2018 Sep 1

Fingerprint

Medical nanotechnology
Antioxidants
Nanoparticles
Reperfusion Injury
Stroke
Nanomedicine
Brain
Blood
Tissue
Active Biological Transport
Therapeutics
Blood-Brain Barrier
Reperfusion
Cause of Death

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)

Cite this

Poellmann, Michael J. ; Bu, Jiyoon ; Hong, Seungpyo. / Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke?. In: Nanomedicine. 2018 ; Vol. 13, No. 18. pp. 2327-2340.
@article{7a4cb5f7d99b496d9034dca64c1c5a3a,
title = "Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke?",
abstract = "Ischemic stroke is a leading cause of death and disability worldwide and is in urgent need of new treatment options. The only approved treatment for stroke restores blood flow to the brain, but much of the tissue damage occurs during the subsequent reperfusion. Antioxidant therapies that directly address ischemia-reperfusion injury have shown promise in preclinical results. In this review, we discuss that reformulating antioxidant therapies as nanomedicine can potentially overcome the barriers that have kept these therapies from succeeding in the clinic. We begin by reviewing the pathophysiology of ischemic stroke with a focus on the effects of reperfusion injury. Next, we review nanotherapeutic systems designed to treat the disease with a focus on those addressing reperfusion injury. Mechanisms of passive and active transport required to traverse a blood-brain barrier are discussed. Finally, we conclude by outlining design parameters for potentially successful nanomedicines as front-line therapeutics for ischemic stroke.",
author = "Poellmann, {Michael J.} and Jiyoon Bu and Seungpyo Hong",
year = "2018",
month = "9",
day = "1",
doi = "10.2217/nnm-2018-0084",
language = "English",
volume = "13",
pages = "2327--2340",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "18",

}

Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke? / Poellmann, Michael J.; Bu, Jiyoon; Hong, Seungpyo.

In: Nanomedicine, Vol. 13, No. 18, 01.09.2018, p. 2327-2340.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke?

AU - Poellmann, Michael J.

AU - Bu, Jiyoon

AU - Hong, Seungpyo

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Ischemic stroke is a leading cause of death and disability worldwide and is in urgent need of new treatment options. The only approved treatment for stroke restores blood flow to the brain, but much of the tissue damage occurs during the subsequent reperfusion. Antioxidant therapies that directly address ischemia-reperfusion injury have shown promise in preclinical results. In this review, we discuss that reformulating antioxidant therapies as nanomedicine can potentially overcome the barriers that have kept these therapies from succeeding in the clinic. We begin by reviewing the pathophysiology of ischemic stroke with a focus on the effects of reperfusion injury. Next, we review nanotherapeutic systems designed to treat the disease with a focus on those addressing reperfusion injury. Mechanisms of passive and active transport required to traverse a blood-brain barrier are discussed. Finally, we conclude by outlining design parameters for potentially successful nanomedicines as front-line therapeutics for ischemic stroke.

AB - Ischemic stroke is a leading cause of death and disability worldwide and is in urgent need of new treatment options. The only approved treatment for stroke restores blood flow to the brain, but much of the tissue damage occurs during the subsequent reperfusion. Antioxidant therapies that directly address ischemia-reperfusion injury have shown promise in preclinical results. In this review, we discuss that reformulating antioxidant therapies as nanomedicine can potentially overcome the barriers that have kept these therapies from succeeding in the clinic. We begin by reviewing the pathophysiology of ischemic stroke with a focus on the effects of reperfusion injury. Next, we review nanotherapeutic systems designed to treat the disease with a focus on those addressing reperfusion injury. Mechanisms of passive and active transport required to traverse a blood-brain barrier are discussed. Finally, we conclude by outlining design parameters for potentially successful nanomedicines as front-line therapeutics for ischemic stroke.

UR - http://www.scopus.com/inward/record.url?scp=85054889382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054889382&partnerID=8YFLogxK

U2 - 10.2217/nnm-2018-0084

DO - 10.2217/nnm-2018-0084

M3 - Review article

C2 - 30284494

AN - SCOPUS:85054889382

VL - 13

SP - 2327

EP - 2340

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 18

ER -